S&P 500
(0.31%) 5 116.00 points
Dow Jones
(0.30%) 38 355 points
Nasdaq
(0.37%) 15 986 points
Oil
(-0.98%) $83.03
Gas
(5.36%) $2.03
Gold
(0.34%) $2 355.10
Silver
(0.50%) $27.67
Platinum
(4.17%) $960.55
USD/EUR
(-0.27%) $0.932
USD/NOK
(-0.44%) $10.98
USD/GBP
(-0.57%) $0.796
USD/RUB
(1.63%) $93.37

リアルタイムの更新: Apollo Endosurgery Inc [APEN]

取引所: NASDAQ セクター: Healthcare 産業: Medical Devices
最終更新日時4 4月 2023 @ 05:00

0.00% $ 10.00

Live Chart Being Loaded With Signals

Commentary (4 4月 2023 @ 05:00):

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope...

Stats
本日の出来高 1.64M
平均出来高 1.33M
時価総額 579.72M
EPS $0 ( 2024-03-28 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -9.43
ATR14 $0.0390 (0.39%)
Insider Trading
Date Person Action Amount type
2023-04-04 Mcgaughy R Kent Jr Sell 400 675 Common Stock
2023-04-04 Mcgaughy R Kent Jr Sell 38 667 Stock Option (Right to Buy)
2023-04-04 Cpmg Inc Sell 400 675 Common Stock
2023-04-04 Barr John R Sell 44 082 Common Stock
2023-04-04 Barr John R Sell 5 271 Non-Qualified Stock Option (right to buy)
INSIDER POWER
-16.28
Last 98 transactions
Buy: 5 638 377 | Sell: 4 907 735

ボリューム 相関

長: 0.13 (neutral)
短: 0.00 (neutral)
Signal:(66.037) Neutral

Apollo Endosurgery Inc 相関

10 最も正の相関
NETE0.955
MDGL0.952
RAVN0.922
SRAC0.9
UFPT0.886
AGYS0.883
NRIM0.882
PODD0.879
TSBK0.879
AMRB0.875
10 最も負の相関
BVXV-0.948
SNPX-0.938
SVAC-0.935
FREQ-0.934
PAIC-0.933
SVOK-0.928
TSP-0.923
ALTM-0.922
ZI-0.919
SGRP-0.917

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Apollo Endosurgery Inc 相関 - 通貨/商品

The country flag -0.24
( neutral )
The country flag 0.25
( neutral )
The country flag 0.08
( neutral )
The country flag -0.16
( neutral )
The country flag -0.19
( neutral )
The country flag 0.32
( neutral )

Apollo Endosurgery Inc 財務諸表

Annual 2022
収益: $76.86M
総利益: $42.43M (55.20 %)
EPS: $-0.980
FY 2022
収益: $76.86M
総利益: $42.43M (55.20 %)
EPS: $-0.980
FY 2021
収益: $62.99M
総利益: $34.96M (55.50 %)
EPS: $-0.820
FY 2020
収益: $42.05M
総利益: $22.24M (52.90 %)
EPS: $-0.990

Financial Reports:

No articles found.

Apollo Endosurgery Inc

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。